Bob Bailer | Senior Director, Vaccines
Q² Solutions

Bob Bailer, Senior Director, Vaccines, Q² Solutions

Joined Q2 Solutions as the Senior Director for Vaccines in August of 2019. In this role he oversees all aspects of the immunogenicity testing of vaccine products inclusive of the full assay life cycle from R&D through clinical testing. Prior to his current position he was the Director of the Immunogenicity Testing Laboratory at the NIH/NIAID/Vaccine Research Center since 2002. In this role he oversaw the immunogenicity testing for all VRC clinical trials of vaccine and broadly neutralizing antibodies. Immediately preceding the position at the NIH, Bob spend 4 years at Merck in a role as technical support for analytical testing and release for vaccines and biologicals.


Day 2, April 8 @ 15:40

Impact of pre-existing immunity on the outcome of vector-based vaccine and gene therapy clinical trials: Evolution of delivery-vector viral neutralization assays

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates